Sanofi’s Open Innovation Access Platform (OIAP) in Strasbourg, France, is a collaborative scientific unit that combines expertise in biochemistry, cell biology, high-throughput screening, drug design, and medicinal chemistry.
Our mission is to develop and advance a portfolio of innovative research projects from target validation to lead optimization, supported by Sanofi Units/Divisions in partnership with academic or biotech groups, in order to offer novel solutions in areas of unmet medical…
via http://ift.tt/1puljGF
No comments:
Post a Comment